Publication | Closed Access

Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells

Tumor BiologyOncologyOncogenic AgentMedicineCancer BiologyErlotinib-induced CytotoxicityPharmacologyCell BiologyLung CancerCancer Research